• total homocysteine
  • Posttreatment total homocysteine in patients varied widely (15-285, median 92 ╬╝mol/L), but was not correlated with ADMA or other measured variables. (springer.com)
  • In three newly-diagnosed patients, marked reduction of total homocysteine during treatment produced minimal changes in ADMA. (springer.com)
  • The aims of this study were to document the levels of cobalamin, folate, methylmalonic acid (MMA) and total homocysteine (tHcy) in serum and their relations to symptoms, clinical findings, and other factors in order to improve the possibilities of detecting early deficiency of vitamin B12 or folate, and to study the effects of cobalamin and folic acid treatment over a three-year period. (diva-portal.org)
  • plasma homocysteine
  • We investigated whether ADMA levels are elevated in CBS patients with and without renal impairment, and whether lowering plasma homocysteine also lowers ADMA. (springer.com)
  • Methods We measured plasma homocysteine, arginine, asymmetric and symmetric dimethylarginines, nitrate + nitrite, creatinine and cystatin C in 23 CBS-deficient patients and 24 age-matched controls. (springer.com)
  • Background -Increasing evidence indicates that elevated plasma homocysteine levels are associated with an increased risk of atherosclerosis and endothelial dysfunction, although little specific information on the mechanisms responsible for the atherogenic effects of homocysteine or on the in vivo contribution made by hyperhomocysteinemia to atherosclerosis is currently available. (ahajournals.org)
  • Moderate hyperhomocysteinemia (plasma homocysteine levels 3- to 4-fold higher than control) significantly exacerbated neointima formation. (ahajournals.org)